Skip to main content
Fig. 6 | BMC Cancer

Fig. 6

From: Bexarotene inhibits the viability of non-small cell lung cancer cells via slc10a2/PPARγ/PTEN/mTOR signaling pathway

Fig. 6

Slc10a2 via PPARγ plays an important role in the proliferation of A549 cells with the treatment of bexarotene. a The proliferation rate of A549 cells treated with bexarotene, bexarotene in combination with GW9662 respectively, A549 cells without any treatment as control group. b The proliferation rate of slc10a2 overexpressed A549 cells treated with bexarotene, bexarotene in combination with GW9662 respectively, A549 cells without any treatment as control group. All experiments were repeated 3 times

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us